Azitra, Inc. (NYSEAMERICAN:AZTR) Sees Large Increase in Short Interest

Azitra, Inc. (NYSEAMERICAN:AZTR) saw a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,368,917 shares, an increase of 6,463.0% from the August 15th total of 20,858 shares. Based on an average daily volume of 4,230,483 shares, the short-interest ratio is presently 0.3 days. Approximately 2.3% of the shares of the company are short sold.

Azitra Stock Performance

AZTR traded up $0.00 during trading on Thursday, hitting $0.18. The stock had a trading volume of 545,541 shares, compared to its average volume of 9,161,490. The company has a 50 day simple moving average of $0.15 and a 200-day simple moving average of $0.19. Azitra has a 12 month low of $0.10 and a 12 month high of $1.09.

Azitra (NYSEAMERICAN:AZTR) last posted its quarterly earnings data on Wednesday, August 12th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.05). As a group, analysts expect that Azitra will post -0.25 earnings per share for the current year.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.